Stem cell-derived intestinal organoids: a novel modality for IBD

18Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The organoids represent one of the greatest revolutions in the biomedical field in the past decade. This three-dimensional (3D) micro-organ cultured in vitro has a structure highly similar to that of the tissue and organ. Using the regeneration ability of stem cells, a 3D organ-like structure called intestinal organoids is established, which can mimic the characteristics of real intestinal organs, including morphology, function, and personalized response to specific stimuli. Here, we discuss current stem cell-based organ-like 3D intestinal models, including understanding the molecular pathophysiology, high-throughput screening drugs, drug efficacy testing, toxicological evaluation, and organ-based regeneration of inflammatory bowel disease (IBD). We summarize the advances and limitations of the state-of-the-art reconstruction platforms for intestinal organoids. The challenges, advantages, and prospects of intestinal organs as an in vitro model system for precision medicine are also discussed. [Figure not available: see fulltext.]

Cite

CITATION STYLE

APA

Tian, C. mei, Yang, M. feng, Xu, H. ming, Zhu, M. zheng, Yue, N. N., Zhang, Y., … Li, D. feng. (2023, December 1). Stem cell-derived intestinal organoids: a novel modality for IBD. Cell Death Discovery. Springer Nature. https://doi.org/10.1038/s41420-023-01556-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free